In addition, BJJP treatment also promoted the effector function of CD8+T cells by significant increasing the expression of TNF-α and IFN-γ in tumor-infiltrating CD8+ T cells (Supplemental Figure S3B, C). The gene discussed is IFNG; the disease is neoplasm.